Incorporation of technical risk in compound real options has been considered in Cas-simon et al. (2011) concerning the valuation of multi-stage pharmaceutical R&D.There, the technical success probabilities at each development stage were assumed tobe generated independently of each other. This assumption can be unrealistic in manyapplied problems, pharmaceutical R&D included. We present a valuation proceduredealing with dependent success probabilities and random development stage times.This greater flexibility allows a better description of the sequence of decision stagesand results, which in turn, impact the value of the considered project. The theoreticalresults are illustrated through a numerical example that shows the implementation ofthe model to a pharmaceutical R&D problem

Valuation of R&D compound option using Markov chain approach

Villani Giovanni
;
2021-01-01

Abstract

Incorporation of technical risk in compound real options has been considered in Cas-simon et al. (2011) concerning the valuation of multi-stage pharmaceutical R&D.There, the technical success probabilities at each development stage were assumed tobe generated independently of each other. This assumption can be unrealistic in manyapplied problems, pharmaceutical R&D included. We present a valuation proceduredealing with dependent success probabilities and random development stage times.This greater flexibility allows a better description of the sequence of decision stagesand results, which in turn, impact the value of the considered project. The theoreticalresults are illustrated through a numerical example that shows the implementation ofthe model to a pharmaceutical R&D problem
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/369233
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact